Kastle Therapeutics Overview

  • Founded
  • 2015

Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 2

  • Investments
  • 1

Kastle Therapeutics General Information

Description

Developer of biopharmaceutical products designed to help underserved patients with severe diseases. The company is focused on acquiring, developing and commercializing pharmaceuticals for diseases with high unmet medical needs.

Contact Information

Website
www.kastletherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 181 West Madison
  • Suite 3400
  • Chicago, IL 60602
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kastle Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kastle Therapeutics‘s full profile, request access.

Request a free trial

Kastle Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical products designed to help underserved patients with severe diseases. The company is focus
Pharmaceuticals
Chicago, IL
00000000 00

0000 0

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
000000000000000
Monmouth Junction, NJ
000 As of 0000
000000000 -

000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
000000000000000
Parsippany, NJ
000 As of 0000
00000
000000000 00 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kastle Therapeutics Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tris Pharma Private Debt Financed Monmouth Junction, NJ 000 000000000 -
000000 00000000000 Formerly VC-backed Parsippany, NJ 000 00000 000000000 00 00000
00000000 000000000 Formerly VC-backed Marlborough, MA 0000 000000&0
0000000 Formerly VC-backed Emeryville, CA 000 00000 000000&0 00000
00000000 0000 Corporation Gainesville, GA 000 00000 000000 - 000 00000
You’re viewing 5 of 11 competitors. Get the full list »

Kastle Therapeutics Patents

  • 71

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Kastle Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2008230886-A1 Administering antisense oligonucleotides complementary to human apolipoprotein b Active 24-Mar-2007 0000000000
AU-2008230886-B2 Administering antisense oligonucleotides complementary to human apolipoprotein b Inactive 24-Mar-2007 0000000000
AU-2008230886-B9 Administering antisense oligonucleotides complementary to human apolipoprotein b Inactive 24-Mar-2007 0000000000
CA-2682082-A1 Administering antisense oligonucleotides complementary to human apolipoprotein b Inactive 24-Mar-2007 0000000000
EP-2137311-A1 Administering antisense oligonucleotides complementary to human apolipoprotein b Inactive 24-Mar-2007 C12N15/113
To view Kastle Therapeutics’s complete patent history, request access »

Kastle Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 03-May-2016 0000000000 0000 Buildings and Property 00000 000
To view Kastle Therapeutics’s complete investments history, request access »